← Open Payments lookup

JARED BROCK: Open Payments

NPI 1073551248 · COLUMBUS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$999 in 59 payments from 22 companies in 2025. Trend: 2023 $849 · 2024 $649 · 2025 $999

Food & beverage: $999
CompanyPaymentsAmount
ABBVIE INC.10$162
GlaxoSmithKline, LLC.11$139
Novo Nordisk Inc9$136
Vanda Pharmaceuticals Inc.3$78
Boehringer Ingelheim Pharmaceuticals, Inc.3$55
Corium, LLC3$52
Lilly USA, LLC3$48
Takeda Pharmaceuticals U.S.A., Inc.2$44
Phathom Pharmaceuticals, Inc.2$30
Otsuka America Pharmaceutical, Inc.1$29

Products named: VRAYLAR, TRELEGY ELLIPTA, FANAPT, Wegovy, JARDIANCE, Ozempic, Azstarys, TRINTELLIX.

Industry payments across IN — which companies pay providers there.